Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$3.56 - $9.24
Next Earnings Date
May 07 2025
Next Earnings Date
May 07 2025
Last Price
Market Cap | $285.76M |
EV | $296.02M |
Shares Outstanding | 70.21M |
Beta | 1.44 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $8.23 |
P/E 2025E | 14.12x |
P/Revenue 2025E | 0.86x |
Revenue | 8.20% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 9.80% |
EPS | 35.70% |
Operating Cash Flow | 71.20% |
Free Cash Flow | 74.70% |
Gross Margin 2025E | 49.96% |
Net Profit Margin 2025E | -17.91% |
ROE 2025E | 6.71% |
ROCE 2024 | -18.99% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Health Catalyst, Inc.
HCAT
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Burton, Daniel
Employees
1,500
Website
www.healthcatalyst.comIPO Date
2019-07-25
Headquarters
10897 South River Front Parkway, Suite 300, South Jordan, Utah, 84095, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved